您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8111 处方药 7730 非处方药 265 保健品/医疗用具 116

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国际免费电话:
QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 美国药房
产地国家: 意大利
所属类别: 神经系统药物->注意力缺陷综合症
处方药:处方药
包装规格: 5毫克/毫升 1毫升/安培 10安培/盒
计价单位:
  点击放大  
生产厂家英文名:
Janssen Pharmaceuticals, Inc.
该药品相关信息网址1:
https://www.rxlist.com/haldol-drug.htm
原产地英文商品名:
Haldol 5mg/ml 1 mL/AMPULE 10 AMPULE/BOX
原产地英文药品名:
Haloperidol
中文参考商品译名:
氟哌啶醇 5毫克/毫升 1毫升/安培 10安培/盒
中文参考药品译名:
氟哌啶醇
原产地国家批准上市年份:
1971/05/18
英文适应病症1:
schizophrenia
英文适应病症2:
control of tics and vocal utterances of Tourette's Disorder
临床试验期:
完成
中文适应病症参考翻译1:
精神分裂症
中文适应病症参考翻译2:
控制Tourette's Disorder的抽搐和发声
药品信息:

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201921205255413.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文Haldol处方资料(仅供参考)


【英文名称】
Haldol

【适用证】

精神分裂症

控制Tourette's Disorder的抽搐和发声

【禁忌症】

HALDOL(氟哌啶醇)禁用于任何原因的严重毒性中枢神经系统抑制或昏迷状态以及对该药物过敏或患有帕金森病的个体。

【用法用量】

孕妇的用量

通过口服或肠胃外途径给予通常最大人体剂量氟哌啶醇2至20倍的啮齿动物显示吸收发生率增加,生育力降低,分娩延迟和幼仔死亡率增加。 在该范围内的剂量下,在大鼠,兔或狗中没有报道致畸作用,但在给予通常最大人剂量的15倍的小鼠中观察到了腭裂。 小鼠的腭裂似乎是对压力或营养不平衡以及各种药物的非特异性反应,并且没有证据表明这种现象与大多数这些药物的可预测的人类风险有关。

在孕妇中没有使用HALDOL(氟哌啶醇)的良好对照研究。 然而,有报道称,在母亲使用HALDOL以及怀孕前三个月怀疑有致畸潜力的其他药物后,观察到肢体畸形的病例。 在这些案例中没有建立因果关系。 由于这种经验不排除由于HALDOL导致胎儿受损的可能性,因此该药物应该在怀孕期间或在可能怀孕的女性中使用,只有在该益处明确证明对胎儿有潜在风险的情况下。 在药物治疗期间不应对婴儿进行护理。

【INDICATIONS】

HALDOL (haloperidol) is indicated for use in the treatment of schizophrenia.

HALDOL is indicated for the control of tics and vocal utterances of Tourette's Disorder.

【CONTRAINDICATIONS】

HALDOL (haloperidol) is contraindicated in severe toxic central nervous system depression or comatose states from any cause and in individuals who are hypersensitive to this drug or have Parkinson's disease

【Usage in Pregnancy】

Rodents given 2 to 20 times the usual maximum human dose of haloperidol by oral or parenteral routes showed an increase in incidence of resorption, reduced fertility, delayed delivery and pup mortality. No teratogenic effect has been reported in rats, rabbits or dogs at dosages within this range, but cleft palate has been observed in mice given 15 times the usual maximum human dose. Cleft palate in mice appears to be a nonspecific response to stress or nutritional imbalance as well as to a variety of drugs, and there is no evidence to relate this phenomenon to predictable human risk for most of these agents.

There are no well controlled studies with HALDOL (haloperidol) in pregnant women. There are reports, however, of cases of limb malformations observed following maternal use of HALDOL along with other drugs which have suspected teratogenic potential during the first trimester of pregnancy. Causal relationships were not established in these cases. Since such experience does not exclude the possibility of fetal damage due to HALDOL, this drug should be used during pregnancy or in women likely to become pregnant only if the benefit clearly justifies a potential risk to the fetus. Infants should not be nursed during drug treatment.

---------------------------------------------------------------
详细处方信息以本药内容附件PDF文件(201921205255413.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2019-2-12
附件:
201921205255413.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com